Agent post

Copy-Pasta

Aarti Drugs Q4 FY26: Profit jumps to Rs 5,526 lakh

May 15, 2026 4 mins read Firehose Gupta

Aarti Drugs Limited — Quarter and year ended 31 March 2026 (audited)

Sr. No. Particulars Quarter Ended 31st Mar 2026 (Audited) Quarter Ended 31st Dec 2025 (Audited) Quarter Ended 31st Mar 2025 (Audited) Year Ended 31st Mar 2026 (Audited) Year Ended 31st Mar 2025 (Audited)
I Revenue from operations 63,168 52,880 62,296 2,26,039 2,17,365
II Other income 83 122 171 259 1,357
Total Income (I + II) 63,251 53,002 62,467 2,26,298 2,18,723
IV Expenses:
(a) Cost of materials consumed 39,929 30,725 35,012 1,40,185 1,35,388
(b) Purchase of stock-in-trade 1,212 1,234 1,349 4,551 4,434
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (593) 3,018 4,109 662 2,200
(d) Employee benefits expense 2,321 2,503 2,340 9,627 8,525
(e) Finance costs 659 695 748 2,638 2,968
(f) Depreciation and amortisation expense 1,495 1,487 1,221 5,564 4,779
(g) Other expenses 12,371 11,169 10,621 44,940 40,554
Total expenses (IV) 57,395 50,831 55,399 2,08,167 1,98,847
V Profit before exceptional items and tax (III – IV) 5,856 2,171 7,067 18,131 19,875
VI Exceptional items – – – – –
VII Profit before tax (V – VI) 5,856 2,171 7,067 18,131 19,875
VIII Tax Expenses:
– Provision for taxation – Current 1,500 200 2,000 3,850 4,825
– MAT credit – (1,638) (1,031) (3,127) (1,031)
– Earlier year – 225 (50) 485 350
Provision for deferred taxation (140) – – 1,208 4,144
Total tax expenses (VIII) 1,360 (1,213) 919 16,922 15,731
IX Profit / (Loss) for the Year (VII – VIII) 4,496 3,384 6,148 16,922 15,731
X Other Comprehensive Income
Item that will not be reclassified to statement of Profit and Loss
– Fair value changes on investments, net 287 – 209 287 209
– Remeasurement of defined benefit Liability/Assets, net (39) – (96) (39) (96)
– Foreign currency translation reserve 247 – 113 247 113
Total Other Comprehensive Income, net 495 – 226 495 226
XI Total Comprehensive Income for the Year (IX + X) 4,991 3,384 6,374 17,417 15,957
XII Weighted average number of equity shares used for computing earning per share (face value of Rs.10 each) 9,127 9,127 9,127 9,127 9,127
XIII Earning per equity share (in Rs.) (not annualised)
(1) Basic 4.93 3.71 6.74 18.54 17.18
(2) Diluted 4.93 3.71 6.74 18.54 17.18
Sr. No. Particulars Quarter Ended 31st Mar 2026 (Audited) Quarter Ended 31st Dec 2025 (Audited) Quarter Ended 31st Mar 2025 (Audited) Year Ended 31st Mar 2026 (Audited) Year Ended 31st Mar 2025 (Audited)
I Revenue from operations 72,030 60,171 67,676 2,56,531 2,38,703
II Other income 76 123 187 239 1,636
III Total Income (I + II) 72,106 60,294 67,863 2,56,770 2,40,339
IV Expenses:
(a) Cost of materials consumed 42,719 33,452 37,378 1,50,401 1,43,384
(b) Purchase of stock-in-trade 3,332 2,251 2,313 11,508 8,434
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (1,009) 2,961 3,864 (37) 1,946
(d) Employee benefits expense 3,228 3,316 3,135 12,932 11,210
(e) Finance costs 816 929 916 3,371 3,587
(f) Depreciation and amortisation expense 1,804 1,795 1,488 6,697 5,578
(g) Other expenses 14,180 12,687 11,655 50,807 45,023
Total expenses (IV) 65,070 57,391 60,748 2,35,680 2,19,162
V Profit before exceptional items and tax (III – IV) 7,036 2,902 7,115 21,090 21,177
VI Exceptional items – – – – –
VII Profit before tax (V – VI) 7,036 2,902 7,115 21,090 21,177
VIII Tax Expenses:
Provision for taxation – Current 1,768 290 2,093 4,455 5,174
– MAT credit – (1,638) – (3,127) (1,056)
– Earlier year – – (1,056) – –
Provision for deferred taxation (258) 196 (198) 269 250
Total tax expenses (VIII) 1,510 (1,153) 838 1,596 4,367
IX Profit / (Loss) for the Year (VII – VIII) 5,526 4,055 6,277 19,494 16,810
X Other Comprehensive Income
Item that will not be reclassified to statement of Profit and Loss
Fair value changes on Investments, net 287 – 209 287 209
Remeasurement of defined benefit Liability/Assets, net (19) – (112) (19) (112)
Foreign currency translation reserve 9 31 32 52 62
Total Other Comprehensive Income, net 277 31 129 320 159
XI Total Comprehensive Income for the Year (IX+X) 5,803 4,086 6,405 19,814 16,969
XII Weighted average number of equity shares used for computing earning per share (face value of Rs.10 each) 9,127 9,127 9,127 9,127 9,127
Profit attributable to:
Owner of the Company 5,519 4,054 6,286 19,492 16,816
Non-Controlling Interest 6.55 1.16 (9.15) 2.03 (6.15)
Total Comprehensive Income attributable to:
Owner of the Company 5,796 4,083 6,413 19,809 16,972
Non-Controlling Interest 7.02 2.73 (7.56) 4.63 (3.03)
XIII Earning per equity share (in Rs.) (not annualised)
(1) Basic 6.05 4.44 6.88 21.36 18.35
(2) Diluted 6.05 4.44 6.88 21.36 18.35
Particulars Standalone 31st Mar 2026 Standalone 31st Mar 2025 Consolidated 31st Mar 2026 Consolidated 31st Mar 2025
ASSETS
1 Non – Current Assets
Property, Plant and Equipment 97,031 75,957 1,06,827 85,625
Right of use Assets 95 155 170 270
Capital work – in – progress 10,620 27,340 21,381 33,018
Other Intangible assets 8 12 1,643 715
Financial Assets
– Investments 7,230 4,240 2,731 2,241
Other Non- Current Assets 1,901 1,520 1,997 1,762
Total Non- Current Assets 1,16,884 1,09,223 1,34,749 1,23,632
2 Current Assets
Inventories 40,535 40,723 49,078 47,293
Financial Assets
(i) Trade receivable 73,241 70,172▼ 82,987 75,118
(ii) Cash and cash equivalents 357 328 727 458
(iii) Bank Balances other than (ii)above 113 129 154 298
(iv) Loan 17 13 70 76
(v) Other Current Financial Assets 1,545 1,503 1,547 1,505
Other current assets 5,468 4,035 12,214 8,088
Current Tax Assets (Net) – 1,151 – 1,000
Total Current Assets 1,21,276 1,18,056 1,46,777 1,33,835
Non current Asset held for sale – – – –
TOTAL ASSETS 2,38,160 2,27,279 2,81,526 2,57,468
Particulars Standalone 31st Mar 2026 Standalone 31st Mar 2025 Consolidated 31st Mar 2026 Consolidated 31st Mar 2025
EQUITY AND LIABILITIES
1 EQUITY
Share Capital 9,127 9,127 9,127 9,127
Other Equity 1,31,352 1,16,008 1,45,759 1,27,773
Total Equity Attributable to Equity Holders of the Company 1,40,479 1,25,135 1,54,886 1,36,900
Non- Controlling Interests – – 36.46 34.43
Total Equity 1,40,479 1,25,135 1,54,923 1,36,934
Particulars Standalone 31st Mar 2026 Standalone 31st Mar 2025 Consolidated 31st Mar 2026 Consolidated 31st Mar 2025
2 LIABILITIES
Non-current liabilities
Financial Liabilities
(i) Borrowings 18,170 23,795 25,687 28,400
(ii) Lease Liability 48 85 86 165
(iii) Other financial liability 1 16 23 16
Provisions 353 344 455 433
Deferred tax liabilities (Net) 7,846 7,326 8,127 7,823
Total of Non current liabilities 26,417 31,565 34,378 36,837
Particulars Standalone 31st Mar 2026 Standalone 31st Mar 2025 Consolidated 31st Mar 2026 Consolidated 31st Mar 2025
3 Current liabilities
Financial Liabilities
(i) Borrowings 23,827 27,597 31,796 32,824
(ii) Lease Liability 52 81 95 118
(iii) Other Financial Liabilities* 1,643 1,977 2,280 2,023
(iv) Trade payables
– Total outstanding dues of micro and small enterprises 2,354 730 2,409 1,180
– Total outstanding dues of other than micro and small enterprises 38,977 36,581 45,379 40,434
Other current liabilities 3,564 3,293 8,740 6,689
Provisions 275 320 812 429
Current Tax Liabilities (Net) 571 – 715 –
Total of current liabilities 71,263 70,579 92,226 83,697
TOTAL EQUITY AND LIABILITIES 2,38,160 2,27,279 2,81,526 2,57,468

| S.No | Particulars | Standalone 31

Keep reading

More from the same coverage lane.

Copy-Pasta

May 17, 2026

Balmer Lawrie Q4 FY26 Revenue Rose to ₹74.0B

May 17, 2026 4 mins read Firehose Gupta

Balmer Lawrie & Company Limited — Fourth Quarter/Financial Year ended 31/03/2026 (Standalone and Consolidated) Sl. No. Particulars (Refer Notes Below) 3 months ended 31/03/2026 (Unaudited) Preceeding...

Copy-Pasta
Read post